Accession Number : ADA333467

Title :   Analysis Plan: Study to Measure the Cost of CHAMPUS-Eligible Participants in Southwest Oncology Group NCI Cooperative Program Cancer Clinical Trials 1988-1996: Technical Report No. 1.

Descriptive Note : Interim rept. Oct 88-Sep 96,

Corporate Author : CENTER FOR HEALTHCARE EDUCATION AND STUDIES FORT SAM HOUSTON TX

Personal Author(s) : Optenbeerg, Scott A. ; Schneider, Sandra L. ; Potosky, Arnold ; McCabe, Mary

PDF Url : ADA333467

Report Date : 01 DEC 1997

Pagination or Media Count : 79

Abstract : The National Cancer Institute's Division of Cancer Treatment, Diagnosis, and Centers (DCTDC) has initiated effort to expand clinical trial participation by proposing coverage agreement of NCI clinical trial participants with various third party payers. An agreement was signed with the Department of Defense (DOD) to allow patients who are beneficiaries of TRICAKE/CHAMPUS to participate in, and be reimbursed for, NCI-sponsored clinical cancer treatment trials. This study is a cancer demonstration project pilot study to evaluate the potential cost impact of the NCI/DOD agreement. The initial study phase identified CHAMPUS eligible beneficiaries (CEBs) diagnosed with cancer and enrolled in NCI clinical trials (1988-1996). CEBs treated for cancer of the breast, prostate, colon, lung, leukemia, and lymphoma in phase 2 and 3 adjuvant, advanced/ recurrent disease trials were identified. The second phase of this study will be to determine the cost of the clinical trials by using TRICARE/CHAMPUS claims data from resource utilization of inpatient and outpatient (ambulatory) professional services and institutional costs CEB enrolled in clinical trials will be compared to a non-trial group disease and clinical matched CEB cancer cases.

Descriptors :   *ECONOMIC IMPACT, *PILOT STUDIES, *CANCER, *CHAMPUS, DEPARTMENT OF DEFENSE, COST ANALYSIS, DEMOGRAPHY, CLINICAL MEDICINE, LUNG, PATIENTS, MEDICAL RESEARCH, PHARMACOLOGY, MAMMARY GLANDS, LEUKEMIA, LYMPHOMAS, BREAST CANCER, COLON CANCER, PROSTATE CANCER.

Subject Categories : Economics and Cost Analysis
      Personnel Management and Labor Relations
      Test Facilities, Equipment and Methods

Distribution Statement : APPROVED FOR PUBLIC RELEASE